Arcadia Biosciences' Q4 revenue falls 26%, net loss narrows

robot
Abstract generation in progress

Arcadia Biosciences (RKDA) reported a 26% decrease in its fourth-quarter revenue, though its net loss for the period narrowed. The article, sourced from Reuters, provides this financial update for the company.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments